Alain CornetDear Members,
You might have received a mail from PatientView, seeking input to their study on the corporate reputation of the pharmaceutical industry in 2015— from the perspective of patient groups. We also know that some of you have not received it, and would be interested in taking part. We therefore relay the information so that you can make your own decision as to whether you would or not like to take part.
Yours
Alain Cornet
Secretariat – LUPUS EUROPE
REQUEST RECEIVED FROM PATIENT VIEW:
For the 5th year, PatientView is asking health campaigners across the world to help compile the annual CORPORATE REPUTATION INDEX OF PHARMA
• The Index is taken seriously by the pharma industry as part of its efforts to become more patient-friendly.
• The results of this 2015 survey will show you how your colleagues rate the world’s various pharmaceutical companies in 2015 (whether good or bad).
About the questionnaire
The survey is open to any health advocacy organisation worldwide. Please circulate this email to any other patient groups that you think might also be interested. The survey has only 10 very simple questions, and will probably take no more than 10-15 minutes of your time to complete. The survey is anonymous, unless you prefer to specify otherwise.
To be sure your response is made in time, please complete before Monday, 18th January 2016.
To enter the survey, please click on the following live link: http://www.surveymonkey.com/r/corp-reputation-pharma-2015
To thank you for your participation in this study …
… all respondents to any PatientView study get a final copy of the resulting report (if they wish).
A brief statement of clarification
This 2015 study intends to determine how patient groups around the world perceive the pharmaceutical industry, with the aim of improving standards throughout the industry to levels that are satisfactory to patients.
The study is paid for solely by PatientView, a UK-based research and publishing group that specialises in studying trends in the patient-advocacy movement, and which passes valuable and unique information back to patient groups. All NGOs participating in the study can receive a free copy of the report on the survey results (if they wish to). PatientView funds the whole exercise by selling the report to any pharma companies that wish to read it.
Further information about PatientView reports can be found at our website: http://www.patient-view.com/bull-corp-reputation.html
After completing the survey you will be taken to PatientView’s website where you can see press releases for the corporate reputation studies conducted for 2014
Contact details for this study: Alexandra Wyke, CEO, PatientView. Email: alexwyke@patient-view.com
PatientView UK
Tel: 0044-(0)1547-520-965
E-mail: info@patient-view.com
www.patient-view.com
Registered in England Number: 3944382
Registered office:
One Fleet Place London EC4M 7WS
;
